Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $684.27 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $191.09 | 10 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $142.08 | 4 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $87.82 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $61.75 | 4 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $34.77 | 2 | $0 (2024) |
| Alkermes, Inc. | $34.24 | 2 | $0 (2023) |
| Corium, LLC | $33.38 | 2 | $0 (2024) |
| Tempus AI, Inc | $27.63 | 1 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $22.16 | 1 | $0 (2022) |
| Lundbeck LLC | $17.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $180.41 | 10 | Otsuka America Pharmaceutical, Inc. ($46.47) |
| 2023 | $214.73 | 12 | Janssen Pharmaceuticals, Inc ($51.52) |
| 2022 | $147.05 | 8 | E.R. Squibb & Sons, L.L.C. ($124.89) |
| 2019 | $37.87 | 3 | Sunovion Pharmaceuticals Inc. ($37.87) |
| 2017 | $104.21 | 1 | Sunovion Pharmaceuticals Inc. ($104.21) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Neurology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.74 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Neuroscience | ||||||
| 05/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: PSYCHIATRY | ||||||
| 05/13/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $27.63 | General |
| 05/08/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Neuroscience | ||||||
| 04/23/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: PSYCHIATRY | ||||||
| 03/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Central Nervous System | ||||||
| 01/05/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/15/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: CNS | ||||||
| 11/30/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Neuroscience | ||||||
| 09/19/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/09/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/09/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/02/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: CNS | ||||||
| 07/18/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Neuroscience | ||||||
| 07/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.68 | General |
| Category: Cardiovascular | ||||||
| 05/23/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Neuroscience | ||||||
| 03/01/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: PSYCHIATRY | ||||||
| 02/22/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.78 | General |
| Category: Cardiovascular | ||||||
| 12/07/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.96 | General |
| Category: Cardiovascular | ||||||
| 11/22/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.95 | General |
| Category: Cardiovascular | ||||||
| 10/13/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.53 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 251 | 399 | $164,610 | $37,884 |
| 2022 | 1 | 43 | 55 | $20,400 | $5,179 |
| 2020 | 2 | 25 | 60 | $14,822 | $3,596 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 231 | $95,230 | $22,372 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 110 | $33,730 | $7,564 | 22.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 32 | $19,390 | $4,384 | 22.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 26 | 26 | $16,260 | $3,563 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 55 | $20,400 | $5,179 | 25.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 34 | $8,738 | $2,246 | 25.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 26 | $6,084 | $1,350 | 22.2% |
About Dr. Syed Raza, MD
Dr. Syed Raza, MD is a Psychiatry healthcare provider based in Brick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1457542805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Raza, MD has received a total of $684.27 in payments from pharmaceutical and medical device companies, with $180.41 received in 2024. These payments were reported across 34 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($684.27).
As a Medicare-enrolled provider, Raza has provided services to 319 Medicare beneficiaries, totaling 514 services with total Medicare billing of $46,658. Data is available for 3 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Geriatric Psychiatry
- Location Brick, NJ
- Active Since 08/09/2007
- Last Updated 12/22/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457542805
Products in Payments
- CAMZYOS (Drug) $144.53
- LATUDA (Drug) $142.08
- SPRAVATO (Drug) $87.82
- REXULTI (Drug) $33.87
- Azstarys (Drug) $33.38
- ABILIFY MYCITE (Drug) $29.60
- ELIQUIS (Drug) $27.82
- Nuedexta (Drug) $22.16
- COBENFY (Drug) $18.74
- UZEDY (Drug) $18.23
- ARISTADA (Drug) $17.71
- Austedo XR (Drug) $16.54
- Vivitrol (Drug) $16.53
- Auvelity (Drug) $16.36
- VRAYLAR (Drug) $15.99
- ABILIFY MAINTENA (Drug) $15.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Brick
Dr. Carol Dobrzynski, Md, MD
Psychiatry — Payments: $10,992
Samson Vimalananda, Md, MD
Psychiatry — Payments: $1,973
Nitin Pothen
Psychiatry — Payments: $1,687
Russell Ferstandig, 25Ma03504800, 25MA03504800
Psychiatry — Payments: $746.26
Mr. Eric Berger, Md, MD
Psychiatry — Payments: $689.93
Angelina Singh, Do, DO
Psychiatry — Payments: $387.69